Clinical Trial

Clinical Course Of Disease In Participants With FA-CM

Name: Clinical Course Of Disease In Participants With FA-CM — clinical trial record (NCT06865482)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)

Protocol Amendment History 2 changes

notable Trial sites expanded: 14 -> 19 locations 2026-06-09

notable Trial sites expanded: 10 -> 14 locations 2026-04-16

Trial Details

NCT Number	NCT06865482
Lead Sponsor	Lexeo Therapeutics
Conditions	Friedreich Ataxia, Cardiomyopathy
Enrollment	65 participants
Start Date	2025-09-30
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-06-08